- ECHA
- Consultations
- Harmonised classification and labelling targeted consultations
- Harmonised classification and labelling previous targeted consultations
Harmonised classification and labelling previous targeted consultations
Harmonised classification and labelling previous targeted consultations
These targeted consultations for CLH proposals are closed. The consultations are launched in case further information is needed on a particular hazard class, or if comments are sought on e.g. a specific additional document.
The comments received during the consultation are available on the Registry of CLH intentions until outcome.
There are currently no ongoing consultations.
| (RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate | - | 1101132-67-5 | United Kingdom |
Carc. 2, H351 STOT RE 2, H373 Aquatic Acute 1, H400, M = 10 Aquatic Chronic 1, H410, M=100 |
Details | ||
| 1-isopropyl-4-methylbenzene; p-cymene | 202-796-7 | 99-87-6 | Netherlands |
Flam. Liq. 3, H226, Acute Tox. 3, H331, Asp. Tox. 1, H304, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=1, Aquatic Chronic 3, H412 |
Details | ||
| 2-butoxyethanol; ethylene glycol monobutyl ether | 203-905-0 | 111-76-2 | 603-014-00-0 | Article 77(3) request |
Acute Tox. 4*; H332 Acute Tox. 4*; H312 Acute Tox. 4*; H302 Skin Irrit. 2; H315 Eye Irrit. 2; H319 |
Acute Tox. 3; H331 Acute Tox. 4; H302 Skin Irrit. 2; H315 Eye Irrit. 2; H319 inhalation: ATE = 3 mg/L oral: ATE = 1200 mg/kg bw |
Details |
| 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctan-1-ol | 211-477-1 | 647-42-7 | Germany |
STOT RE2, H373 (skeletal system) Aquatic Chronic 2, H411 |
Details | ||
| 3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate | 259-627-5 | 55406-53-6 | 616-212-00-7 | Denmark |
Acute Tox. 3, H331 Acute Tox. 4, H302, STOT RE 1, H372 (larynx) Eye Dam. 1, H318, Skin Sens. 1, H317, Aquatic Acute 1, H400, M = 10, Aquatic Chronic 1, H410, M = 1 |
Acute Tox. 2, H330, Acute Tox. 4, H302, STOT RE 1, H372 (larynx) Eye Dam. 1, H318, Skin Sens. 1, H317, Aquatic Acute 1, H400, M = 10, Aquatic Chronic 1, H410, M = 10 |
Details |
| butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime | 202-496-6 | 96-29-7 | Germany |
Acute Tox. 4*, H312, Eye Dam. 1, H318, Skin Sens. 1, H317, Carc. 2, H351 |
Acute Tox. 3, H301, Acute Tox. 4, H312, Eye Dam. 1, H318, Skin Sens. 1B, H317, Carc. 1B, H350, STOT SE 3, H336 dermal: ATE = 1848 mg/kg oral: ATE = 100 mg/kg |
Details | |
| Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents and Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbon dioxide | 289-699-3 | 89997-63-7 | Spain |
Acute Tox. 4, H302, Acute Tox. 4, H332, Skin Sens. 1B, H317, Aquatic Acute 1, H400, M-factor=100, Aquatic Chronic 1, H410, M-factor=10 ATE oral = 700 mg/kg bw ATE inhalation = 2.5 mg/L (dusts and mists) |
Details | ||
| clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-one | - | 99129-21-2 | Sweden | Acute Tox. 4, H302, Skin Sens. 1, H317, Aquatic Chronic 3, H412 EUH066 |
Self-react. G, Acute Tox. 4, H302, ATE = 1133 mg/kg bw, Skin Sens. 1, H317, STOT RE 2, H373, Aquatic Acute 1, H400, M-factor=10, Aquatic Chronic 1, H410, M-factor=10, EUH066 |
Details | |
| clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one | 617-258-0 | 81777-89-1 | Denmark |
Acute Tox. 4, H302, Acute Tox. 4, H332, Repr. 1B, H360D, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=1, Aquatic Chronic 1, H410, Aquatic Chronic 1, M-factor=1 |
Details | ||
| Copper compounds | - | - | M-factors for long-term aquatic hazard | Details | |||
| cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; cypermethrin cis/trans +/- 40/60 | 257-842-9 | 52315-07-8 | 607-421-00-4 | Belgium |
Acute Tox. 4*, H332 Acute Tox. 4*, H302 STOT SE 3, H335 Aquatic Acute 1, H400 Aquatic Chronic 1, H410 |
Acute Tox. 4*, H332 Acute Tox. 4*, H302 STOT SE 3, H335 Aquatic Acute 1, H400 (M=100000) Aquatic Chronic 1, H410 (M=1000) |
Details |
| daminozide (ISO); 4-(2,2-dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid | 216-485-9 | 1596-84-5 | Czech Republic | Carc. 1B, H350 | Details | ||
| diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide | 617-446-2 | 83164-33-4 | 616-032-00-9 | United Kingdom | Aquatic Chronic 3, H412 |
Aquatic Acute 1, H400 Aquatic Chronic 1, H410 |
Details |
| Flumioxazin (ISO),N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide | - | 103361-09-7 | 613-166-00-X | Czech Republic |
Repr. 1B, H360D, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=1000, Aquatic Chronic 1, H410, Aquatic Chronic 1, M-factor=1000 |
Repr. 2, H361d, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=1000, Aquatic Chronic 1, H410, Aquatic Chronic 1, M-factor=1000 |
Details |
| Glyphosate | 213-997-4 | 1071-83-6 | 607-315-00-8 | Sweden |
Eye Dam. 1, H318, Aquatic Chronic 2, H411 |
Eye Dam. 1, H318, Aquatic Chronic 2, H411 |
Details |
| hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate; hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate | 443-860-6 | 302776-68-7 | 607-693-00-4 | Germany | Aquatic Chronic 4, H413 | Aquatic Chronic 1, H410, M-factor = 1000 | Details |
| Hexyl salicylate | 228-408-6 | 6259-76-3 | France |
Skin Sens. 1, H317, Repr. 2, H361d |
Details | ||
| lead | 231-100-4 | 7439-92-1 |
082-013-00-1 082-014-00-7 |
Article 77(3) request |
Repr. 1A, H360FD Lact., H362 |
Repr. 1A, H360FD Lact., H362 Aquatic Acute 1, H400; M=1 Aquatic Chronic 1, H410; M=10 |
Details |
| lithium carbonate [1] lithium chloride [2] lithium hydroxide [3] |
209-062-5 231-212-3 215-183-4 |
554-13-2 7447-41-8 1310-65-2 |
TBD | Article 77(3) request |
Repr. 1A, H360FD Lact., H362 |
Details | |
| lithium carbonate [1] lithium chloride [2] lithium hydroxide [3] |
209-062-5 231-212-3 215-183-4 |
554-13-2 7447-41-8 1310-65-2 |
France | Repr. 1A, H360FD | Details | ||
| MCPA-thioethyl (ISO); S-ethyl (4-chloro-2-methylphenoxy)ethanethioate; S-ethyl 4-chloro-o-tolyloxythioacetate | 246-831-4 | 25319-90-8 | 246-831-4 | Poland |
Acute Tox. 4, H302, Aquatic Acute 1, M-factor=10, Aquatic Chronic 1, M-factor=10 |
Details | |
| Melaleuca alternifolia, ext. Melaleuca alternifolia, essential oil; tea tree oil | 285-377-1 |
85085-48-9 68647-73-4 |
Poland |
Flam. Liq. 3, H226, Acute Tox. 4, H302, oral: ATE = 1049 mg/kg bw Acute Tox. 4, H332, inhalation: ATE = 3.64 mg/L (mist) Skin Irrit. 2, H315, Skin Sens. 1B, H317, Repr. 2, H361f, Asp. Tox. 1, H304, Aquatic Acute 1, H400, M-factor=1, Aquatic Chronic 3, H412 |
Details | ||
| methyl methacrylate methyl 2-methylprop-2-enoate methyl 2-methylpropenoate | 201-297-1 | 80-62-6 | 607-035-00-6 | France |
Flam. Liq. 2, H225 Skin Irrit. 2, H315 Skin Sens. 1, H317 STOT SE 3, H335 |
Flam. Liq. 2, H225 Skin Irrit. 2, H315 Resp. Sens. 1, H334 Skin Sens. 1, H317 STOT SE 3, H335 |
Details |
| methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate | 201-297-1 | 80-62-6 | 607-035-00-6 | Article 77(3) request |
Flam. Liq. 2, H225 Skin Irrit. 2, H315 Skin Sens. 1, H317 STOT SE 3, H335 |
Flam. Liq. 2, H225 Resp. Sens. 1, H 334 Skin Irrit. 2, H315 Skin Sens. 1, H317 STOT SE 3, H335 |
Details |
| metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one | 244-209-7 | 21087-64-9 | 606-034-00-8 | Estonia |
Acute Tox. 4*, H302, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=10, Aquatic Chronic 1, H410, Aquatic Chronic 1 |
Acute Tox. 4, H302, STOT RE 2, H373, Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=10, Aquatic Chronic 1, H410, Aquatic Chronic 1, M-factor=100 ATE 322 mg/kg bw |
Details |